[1] PAULING L, MOERTEL C. A proposition:megadoses of vitamin C are valuable in the treatment of cancer[J]. Nutr Rev, 1986, 44(1):28-32.
[2] CREAGAN E T, MOERTEL C. Vitamin C therapy of advanced cancer[J]. N Engl J Med, 1979, 301(25):1399.
[3] PAULING L. For the best of health:how much vitamin C do you need?[J]. Pe Dent J, 1976, 43(3):53-56.
[4] PAULING L. Vitamin C and longevity[J]. Agressologie, 1983, 24(7):317-319.
[5] HENNEKENS C H. Antioxidant vitamins and cancer[J]. Am J Med, 1994, 97(3):S2-S4.
[6] RUANO-RAVINA A, FIGUEIRAS A, FREIRE-GARABAL M, et al. Antioxidant vitamins and risk of lung cancer[J]. Curr Pharm Des, 2006, 12(5):599-613.
[7] KLEIN E A, THOMPSON I M, TANGEN C M, et al. Vitamin E and the risk of prostate cancer:the selenium and vitamin E cancer prevention trial (select)[J]. JAMA, 2011, 306(14):1549-1556.
[8] HALLIWELL B. The antioxidant paradox[J]. Lancet, 2000, 355(9210):1179-1180.
[9] BRIEGER K, SCHIAVONE S, MILLER F J, et al. Reactive oxygen species:from health to disease[J]. Swiss Med Week, 2012, 142:w13659.
[10] BJØRKLUND G, CHIRUMBOLO S. Role of oxidative stress and antioxidants in daily nutrition and human health[J]. Nutrition, 2017, 33:311-321.
[11] WANG X, HAI C X. Novel insights into redox system and the mechanism of redox regulation[J]. Mol Biol Rep, 2016, 43(7):607-628.
[12] 海春旭. 新的抗氧化研究理论简介[C]//第九次全国生物物理大会学术会议论文集. 大连, 2002:133.
[13] 海春旭. 抗氧化剂、抗衰老与疾病控制的研究进展[J]. 疾病控制杂志, 2002, 6(4):289-293.
[14] HALLIWELL B. The antioxidant paradox:less paradoxical now?[J]. Br J Clin Pharmacol, 2013, 75(3):637-644.
[15] BONNER M Y, ARBISER J L. The antioxidant paradox:what are antioxidants and how should they be used in a therapeutic context for cancer[J]. Future Med Chem, 2014, 6(12):1413-1422.
[16] BISWAS S K. Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox?[J]. Oxid Med Cell Longev, 2016, 2016:5698931.
[17] LING S, XU J W. Biological activities of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside in antiaging and antiaging-related disease treat-ments[J]. Oxid Med Cell Longev, 2016, 2016:4973239.
[18] YAN S L, PAN C, YANG X Q, et al. Degradation of Codium cylindricum polysaccharides by H2O2-Vc-ultrasonic and H2O2-Fe2+-ultrasonic treatment:Structural characterization and antioxidant activity[J]. Int J Biol Macromol, 2021, 182:129-135.
[19] BAI H, ZHANG W, QIN X J, et al. Hydrogen peroxide modulates the proliferation/quiescence switch in the liver during embryonic development and posthepatectomy regeneration[J]. Antioxid Redox Signal, 2015, 22(11):921-937.
[20] ONUMAH O E, JULES G E, ZHAO Y, et al. Overexpression of catalase delays G0/G1-to S-phase transition during cell cycle progression in mouse aortic endothelial cells[J]. Free Radic Biol Med, 2009, 46(12):1658-1667.
[21] 于卫华, 刘江正, 王钊, 等. 环孢霉素A对葡萄糖氧化酶诱导的HepG2线粒体功能损伤和细胞凋亡的保护作用[J]. 癌变·畸变·突变, 2014, 26(1):10-15.
[22] NARITA S, SAITO E, SAWADA N, et al. Dietary consumption of antioxidant vitamins and subsequent lung cancer risk:The Japan Public Health Center-based prospective study[J]. Int J Cancer, 2018, 142(12):2441-2460.
[23] DRIVER C, GEORGEOU A. Variable effects of vitamin E on Drosophila longevity[J]. Biogerontology, 2003, 4(2):91-95.
[24] 陈子卓, 徐宇航, 赵九洲, 等. 二苯乙烯苷抗氧化和抗炎作用的机制研究[J]. 癌变·畸变·突变, 2020, 32(2):105-111, 117.
[25] YU W, ZHANG X, WU H, et al. HO-1 is essential for tetrahydroxystilbene glucoside mediated mitochondrial biogenesis and anti-inflammation process in LPS-treated RAW264.7 macrophages[J]. Oxid Med Cell Longev, 2017, 2017:1818575.
[26] XU S F, LIU J, SHI J S, et al. 2,3,4',5-tetrahydroxystilbene-2-O-β-Dglucoside exacerbates acetaminophen-induced hepatotoxicity by inducing hepatic expression of CYP2E1, CYP3A4 and CYP1A2[J]. Sci Rep, 2017, 7:16511.
[27] WANG X, ZHANG W, CHEN H, et al. High selenium impairs hepatic insulin sensitivity through opposite regulation of ROS[J]. Toxicol Lett, 2014, 224(1):16-23.
[28] REUTER S, GUPTA S C, CHATURVEDI M M, et al. Oxidative stress, inflammation, and cancer:how are they linked?[J]. Free Radic Biol Med, 2010, 49(11):1603-1616.
[29] OZBEN T. Antioxidant supplementation on cancer risk and during cancer therapy:an update[J]. Curr Top Med Chem, 2015, 15(2):170-178.
[30] MOLONEY J N, COTTER T G. ROS signalling in the biology of cancer[J]. Semin Cell Dev Biol, 2018, 80:50-64.
[31] LIU Z, REN Z, ZHANG J, et al. Role of ROS and nutritional antioxidants in human diseases[J]. Front Physiol, 2018, 9:477.
[32] EATON S. The biochemical basis of antioxidant therapy in critical illness[J]. Proc Nutr Soc, 2006, 65(3):242-249.
[33] DAVALLI P, MITIC T, CAPORALI A, et al. ROS, cell senescence, and novel molecular mechanisms in aging and age-related diseases[J]. Oxid Med Cell Longev, 2016, 2016:3565127.
[34] HE S, SHARPLESS N E. Senescence in health and disease[J]. Cell, 2017, 169(6):1000-1011.
[35] 于卫华, 周庆彪, 刘颖, 等. 活性氧调控炎症诱发肿瘤机制的研究进展[J]. 癌变·畸变·突变, 2016, 28(2):158-160, 封3.
[36] DUMONT M, BEAL M F. Neuroprotective strategies involving ROS in Alzheimer disease[J]. Free Radic Biol Med, 2011, 51(5):1014-1026.
[37] GOROSHKO O A, NOVIKOV K N, KUKES V G, et al. Correction of oxidative stress in patients with chronic cerebral ischemia[J]. Klin Med:Mosk, 2016, 94(7):549-553.
[38] RUSSO G L, TEDESCO I, SPAGNUOLO C, et al. Antioxidant polyphenols in cancer treatment:Friend, foe or foil?[J]. Semin Cancer Biol, 2017, 46:1-13.
[39] HONG S Y, HWANG K Y, LEE E Y, et al. Effect of vitamin C on plasma total antioxidant status in patients with paraquat intoxication[J]. Toxicol Lett, 2002, 126(1):51-59.
[40] LIPPMAN S M, HAWK E T. Cancer prevention:from 1727 to milestones of the past 100 years[J]. Cancer Res, 2009, 69(13):5269-5284.
[41] COLLINS A R. Antioxidant intervention as a route t
[42] Pahwa R, Jialal I. Atherosclerosis[M/OL]. Treasure Island:StatPearls Publishing, 2021.[2021-08-11]. https://pubmed.ncbi.nlm.nih.gov/29939576.
[43] 卢春雪, 杨绍杰, 陶荟竹, 等. 衰老机制研究进展[J]. 中国老年学杂志, 2018, 38(1):248-250.
[44] YU W, WANG X, ZHAO J, et al. Stat2-Drp1 mediated mitochondrial mass increase is necessary for pro-inflammatory differentiation of macrophages[J]. Redox Biol, 2020, 37:101761.
[45] MAEDA Y, INOGUCHI T. Oxidative stress and chronic inflammation[J]. Nihon Rinsho, 2016, 74(Sup 2):73-76.
[46] LEAVY O. Inflammation:regulating ROS[J]. Nat Rev Immunol, 2014, 14(6):357.
[47] BRÜNE B, DEHNE N, GROSSMANN N, et al. Redox control of inflammation in macrophages[J]. Antioxid Redox Signal, 2013, 19(6):595-637.
[48] ZHOU R B, YAZDI A S, MENU P, et al. A role for mitochondria in NLRP3 inflammasome activation[J]. Nature, 2011, 469(7329):221-225.
[49] 韩孝先, 刘泽宇, 周庆彪, 等. 线粒体在炎症调控中的作用研究进展[J]. 癌变·畸变·突变, 2017, 29(6):467-470, 475.
[50] MURER S B, AEBERLI I, BRAEGGER C P, et al. Antioxidant supplements reduced oxidative stress and stabilized liver function tests but did not reduce inflammation in a randomized controlled trial in obese children and adolescents[J]. J Nutr, 2014, 144(2):193-201.
[51] MITTLER R. ROS are good[J]. Trends Plant Sci, 2017, 22(1):11-19.
[52] ROWLES J, OLSEN M. Perspectives on the development of antioxidant antiepileptogenic agents[J]. Mini Rev Med Chem, 2012, 12(10):1015-1027.
[53] MENG J, LV Z, ZHANG Y, et al. Precision redox:the key for antioxidant pharmacology[J]. Antioxid Redox Signal, 2021, 34(14):1069-1082.
[54] GONZÁLEZ-BURGOS E, GÓMEZ-SERRANILLOS M P. Terpene compounds in nature:a review of their potential antioxidant activity[J]. Curr Med Chem, 2012, 19(31):5319-5341.o cancer prevention[J]. Eur J Cancer, 2005, 41(13):1923-1930. |
